![Hongying Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hongying Wang
Corporate Officer/Principal chez China Nuokang Bio-Pharmaceutical, Inc.
Postes actifs de Hongying Wang
Sociétés | Poste | Début | Fin |
---|---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 23/11/2009 | - |
Historique de carrière de Hongying Wang
Anciens postes connus de Hongying Wang
Sociétés | Poste | Début | Fin |
---|---|---|---|
Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. | Corporate Officer/Principal | - | - |
Formation de Hongying Wang
Liaoning University | Undergraduate Degree |
Northeastern University | Masters Business Admin |
Statistiques
Internationale
Chine | 4 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. |
- Bourse
- Insiders
- Hongying Wang
- Expérience